IntrinsicIntrinsic
← Scroll for more →

Financial Statements — NRSNW

Balance Sheet

(in millions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021
Cash & Equivalents0.170.673.381.212.647.093.544.3511.06
Total Current Assets0.781.564.401.622.927.567.3811.1011.41
Property, Plant & Equipment0.060.060.070.080.09--------
Total Non-current Assets0.250.130.170.220.270.310.330.350.02
Total Assets1.031.684.581.843.19--------
Total Current Liabilities2.522.201.993.513.463.011.730.740.60
Total Non-current Liabilities*0.070.001.490.041.496.410.370.881.83
Total Liabilities2.592.201.993.544.94--------
Retained Earnings(47.78)(41.37)(36.66)(32.38)(32.07)(29.90)(20.79)(14.64)(8.45)
Total Stockholder Equity(1.56)(0.52)2.58(1.70)(1.87)(1.54)5.629.849.01
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q4 2023Q2 2023Q2 2022
Gross Profit----0.010.01--
Research & Development2.503.45------
Selling, General & Admin2.192.57------
Total Operating Expenses*--6.37--7.13--
Operating Income(4.69)(6.02)--(7.12)(6.85)
Net Income(4.71)(6.26)--(9.11)(6.20)
Basic EPS(0.19)(0.37)--(0.77)(0.55)
Diluted EPS(0.19)(0.37)--(0.77)(0.55)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022
Operating Cash Flow(4.00)(5.75)(4.08)(4.29)
Capital Expenditures0.010.00----
Free Cash Flow*(4.00)(5.75)----
Investing Cash Flow(0.01)0.003.52(6.05)
Financing Cash Flow1.304.324.103.71
← Scroll for more columns →

* Derived from reported values